Keywords
Enterobacter cloacae
Klebsiella pneumoniae
Momordica charantia seed extract
Staphylococcus aureus
How to Cite
Abstract
Momordica charantia (bitter gourd) has long been used in traditional medicine and possesses multiple bioactive phytochemicals with potential antimicrobial properties. This study was aimed to evaluate the antibacterial activity of Momordica charantia seed extracts against selected Gram-positive and Gram-negative bacterial pathogens using the Kirby–Bauer disc diffusion method. Seed extracts of M. charantia were prepared and tested against Gram-positive bacteria and Gram-negative bacteria at a concentration range of 100-800 mg/mL. The strongest inhibition among Gram-positive bacteria was observed against Listeria monocytogenes at all concentrations and highest at 700 mg/mL, whereas for Staphylococcus aureus, inhibition was between 600-700 mg/mL with highest at 700 mg/mL. However, for Bacillus cereus the inhibition was observed between 500-800 mg/mL. As for Gram negative bacteria, inhibitory activity was observed against Acinetobacter baumannii from 700-800 mg/mL and Enterobacter cloacae at 800 mg/mL. No significant antibacterial activity was observed against Streptococcus mutans, Klebsiella pneumoniae, or Salmonella enteritidis. Momordica charantia seed extract possesses selective antibacterial activity against several clinically relevant microorganisms, particularly Gram-positive bacteria and certain multidrug-resistant Gram-negative pathogens. These findings support the medicinal value of M. charantia seeds and highlight its potential as a source of novel antibacterial compound.
References
El-Saadony, M. T., Saad, A. M., Mohammed, D. M., Korma, S. A., Alshahrani, M. Y., Ahmed, A. E., Ibrahim, E. H., Salem, H. M., Alkafaas, S. S., Saif, A. M., Elkafas, S. S., Fahmy, M. A., Abd El-Mageed, T. A., Abady, M. M., Assal, H. Y., El-Tarabily, M. K., Mathew, B. T., AbuQamar, S. F., El-Tarabily, K. A., & Ibrahim, S. A. (2025). Medicinal plants: bioactive compounds, biological activities, combating multidrug-resistant microorganisms, and human health benefits - a comprehensive review. Frontiers in Immunology, 16. https://doi.org/10.3389/fimmu.2025.1491777
Grover, J. K., & Yadav, S. P. (2004). Pharmacological actions and potential uses of Momordica charantia: a review. Journal of Ethnopharmacology, 93(1), 123–132. https://doi.org/10.1016/j.jep.2004.03.035
Tatiya, A. U., & Anil, P. P. (2025). A Comprehensive Review on the Role of Natural Plants in Anti-Bacterial Activity. Journal of Drug Delivery and Therapeutics, 15(7), 116–125. https://doi.org/10.22270/jddt.v15i7.7200
Ríos, J. L., & Recio, M. C. (2005). Medicinal plants and antimicrobial activity. Journal of Ethnopharmacology, 100(1-2), 80–84. https://doi.org/10.1016/j.jep.2005.04.025
Bortolotti, M., Mercatelli, D., & Polito, L. (2019). Momordica charantia, a Nutraceutical Approach for Inflammatory Related Diseases. Frontiers in Pharmacology, 10. https://doi.org/10.3389/fphar.2019.00486
Joseph, B., & Jini, D. (2013). Antidiabetic effects of Momordica charantia (bitter melon) and its medicinal potency. Asian Pacific Journal of Tropical Disease, 3(2), 93–102. https://doi.org/10.1016/s2222-1808(13)60052-3
Muribeca, A. d. J. B., Gomes, P. W. P., Paes, S. S., da Costa, A. P. A., Gomes, P. W. P., Viana, J. d. S., Reis, J. D. E., Pamplona, S. d. G. S. R., Silva, C., Bauermeister, A., Santos, L. d. S., & da Silva, M. N. (2022). Antibacterial Activity from Momordica charantia L. Leaves and Flavones Enriched Phase. Pharmaceutics, 14(9), 1796. https://doi.org/10.3390/pharmaceutics14091796
Tan, S. P., Kha, T. C., Parks, S. E., & Roach, P. D. (2015). Bitter melon (Momordica charantia L.) bioactive composition and health benefits: A review. Food Reviews International, 32(2), 181–202. https://doi.org/10.1080/87559129.2015.1057843
Silviyah, A., & Prodyanatasari, A. (2023). Antibacterial Activity Test of Ethanol Extract of Bitter Gourd Leaves (Momordica Charantia L) Against Acne-Causing Bacteria (Staphylococcus Epidermidis). Cigarskruie: Journal of Educational and Islamic Research, 1(1), 16–24. https://doi.org/10.65190/636403
Kumar, D. S., Sharathnath, K. V., Yogeswaran, P., Harani, A., Sudhakar, K., Sudha, P., & Banji, D. (2010). A medicinal potency of Momordica charantia. International Journal of Pharmaceutical Sciences Review and Research, 1(2), 95-100.
CLSI. (2012). Performance Standards for Antimicrobial Susceptibility Testing. Clinical and Laboratory Standards Institute.
Basch, E., Gabardi, S., & Ulbricht, C. (2003). Bitter melon (Momordica charantia): A review of efficacy and safety. American Journal of Health-System Pharmacy, 60(4), 356–359. https://doi.org/10.1093/ajhp/60.4.356
Alam, S., Asad, M., Asdaq, S. M. B., & Prasad, V. S. (2009). Antiulcer activity of methanolic extract of Momordica charantia L. in rats. Journal of Ethnopharmacology, 123(3), 464–469. https://doi.org/10.1016/j.jep.2009.03.024
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright (c) 2026 Priya Madhavan, Chang Sin Yoong, Lau Huee Hwa, Wong Eng Hwa (Author)